The Biobank Genomics Core offers comprehensive support for translational and clinical sequencing and genotyping projects.
Our primary expertise is genomic sequencing and genotyping, including Next-Generation Sequencing (NGS) based on Illumina NovaSeq platform and array-based genotyping on Illumina’s Infinium platform. We offer whole genome, whole exome, and RNA-seq as well as sequencing for other applications and DNA genotyping for GWAS and EWAS from a variety of specimen types, including blood, saliva, and tissue blocks.
Personalized Medicine Biobank Genomics Core provides service across several genomics technologies including high throughput NGS, library construction for NGS, genotyping, and methylation experiments.
The services at the Biobank Genomics Core are comprised of two core areas.
We have a long history of producing high-quality, dependable, and informative sequencing results for collaborators and clients. Our next-generation sequencing platforms and services include:
The Biobank Genomics Research Core provides flexible, high-quality, high-throughput SNP genotyping for collaborators and clients. Using state-of-the-art automation, our technologies enable throughputs in excess of five million SNP genotypes per day. Whether you are genotyping only one SNP or every SNP within the genome, or want to customize your assay, we have you covered. Our portfolio of genotyping services includes:
Other Infinium chips may be run. Please contact us for more information.
Note: Unless specifically stated to the contrary, Mass General Brigham Personalized Medicine is not affiliated with any vendors mentioned on this site.